HCW Biologics Inc (HCWB) posted a -1.53% change over the last five days signaling a new trend

On Monday, HCW Biologics Inc (NASDAQ: HCWB) opened higher 6.64% from the last session, before settling in for the closing price of $4.22. Price fluctuations for HCWB have ranged from $4.00 to $100.80 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales drop of Healthcare Sector giant was -29.55%. Company’s average yearly earnings per share was noted 85.06% at the time writing. With a float of $1.16 million, this company’s outstanding shares have now reached $2.41 million.

Let’s determine the extent of company efficiency that accounts for 36 employees. In terms of profitability, gross margin is 23.92%, operating margin of -1657.4%, and the pretax margin is -1712.81%.

HCW Biologics Inc (HCWB) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of HCW Biologics Inc is 52.09%, while institutional ownership is 1.20%. The most recent insider transaction that took place on May 16 ’25, was worth 60,002. In this transaction Chief Executive Officer of this company bought 8,054 shares at a rate of $7.45, taking the stock ownership to the 501,911 shares. Before that another transaction happened on May 16 ’25, when Company’s Director bought 1,342 for $7.45, making the entire transaction worth $9,998. This insider now owns 4,075 shares in total.

HCW Biologics Inc (HCWB) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 85.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 55.47% during the next five years compared to -29.55% drop over the previous five years of trading.

HCW Biologics Inc (NASDAQ: HCWB) Trading Performance Indicators

Check out the current performance indicators for HCW Biologics Inc (HCWB). In the past quarter, the stock posted a quick ratio of 0.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.49.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -25.44, a number that is poised to hit 1.80 in the next quarter and is forecasted to reach -5.01 in one year’s time.

Technical Analysis of HCW Biologics Inc (HCWB)

Looking closely at HCW Biologics Inc (NASDAQ: HCWB), its last 5-days average volume was 0.79 million, which is a jump from its year-to-date volume of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 28.17%.

During the past 100 days, HCW Biologics Inc’s (HCWB) raw stochastic average was set at 4.94%, which indicates a significant decrease from 36.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.75% in the past 14 days, which was lower than the 144.94% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.86, while its 200-day Moving Average is $14.55. However, in the short run, HCW Biologics Inc’s stock first resistance to watch stands at $5.46. Second resistance stands at $6.43. The third major resistance level sits at $7.38. If the price goes on to break the first support level at $3.54, it is likely to go to the next support level at $2.59. Now, if the price goes above the second support level, the third support stands at $1.62.

HCW Biologics Inc (NASDAQ: HCWB) Key Stats

There are currently 1,439K shares outstanding in the company with a market cap of 10.86 million. Presently, the company’s annual sales total 2,570 K according to its annual income of -30,020 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -2,200 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.